Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Drug Delivery Firm Acusphere Raises $20M In Eighth Round

April 22, 2003

By Aaron Lorenzo

Drug Delivery Firm Acusphere Raises $20M In Eighth Round

April 22, 2003

By Aaron Lorenzo

Protein Mechanics Pursues In Silico Drug Development

April 21, 2003

By Aaron Lorenzo

Protein Pathways Lands Merck In First Technology Partnership

April 21, 2003

By Aaron Lorenzo

Protein Pathways Lands Merck In First Technology Partnership

April 21, 2003

By Aaron Lorenzo

Protein Mechanics Pursues In Silico Drug Development

April 21, 2003

By Aaron Lorenzo

Biogen Beats Earnings Estimates On Steady Sales, Amevive Growth

April 18, 2003

By Aaron Lorenzo

Biogen Beats Earnings Estimates On Steady Sales, Amevive Growth

April 18, 2003

By Aaron Lorenzo

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma

April 16, 2003

By Aaron Lorenzo

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma

April 16, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...